Metabolic syndrome, chronic kidney, and cardiovascular diseases: Role of adipokines

Cardiology Research and Practice

Volumn 1, Issue 1, 2011, Pages

  Tesauro, Manfredi ^a   Canale, Maria Paola ^a   Rodia, Giuseppe ^a   Di Daniele, Nicola ^a   Lauro, Davide ^a   Scuteri, Angelo ^b   Cardillo, Carmine ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b INRCA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADIPSIN; ENDOTHELIN 1; GHRELIN; GLUCOSE TRANSPORTER 4; INFLIXIMAB; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SOMATOMEDIN B; SOMATOMEDIN C; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ALBUMINURIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DRUG EFFECT; FOCAL GLOMERULOSCLEROSIS; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE; METABOLIC SYNDROME X; MICROALBUMINURIA; NEPHROSCLEROSIS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION;

EID: 79959410389     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.4061/2011/653182     Document Type: Review

References (146)

1. Visscher T. L. S., Seidell J. C., The public health impact of obesity Annual Review of Public Health 2001 22 355 375 (Pubitemid 32452512)
2. French S. A., Story M., Jeffery R. W., Environmental influences on eating and physical activity Annual Review of Public Health 2001 22 309 335 (Pubitemid 32452510)
3. Muniyappa R., Montagnani M., Koh K. K., Quon M. J., Cardiovascular actions of insulin Endocrine Reviews 2007 28 5 463 491 (Pubitemid 47236334)
4. Avogaro A., De Kreutzenberg S. V., Mechanisms of endothelial dysfunction in obesity Clinica Chimica Acta 2005 360 1-2 9 26 (Pubitemid 41226497)
5. Henegar J. R., Bigler S. A., Henegar L. K., Tuagi S. C., Hall J. E., Functional and structural changes in the kidney in the early stages of obesity Journal of the American Society of Nephrology 2001 12 6 1211 1217 (Pubitemid 32472634)
6. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y., Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization New England Journal of Medicine 2004 351 13 1296 1370
7. Shlipak M. G., Sarnak M. J., Katz R., Fried L. F., Seliger S. L., Newman A. B., Siscovick D. S., Stehman-Breen C., Cystatin C and the risk of death and cardiovascular events among elderly persons New England Journal of Medicine 2005 352 20 2049 2060 (Pubitemid 40664306)
8. Danziger J., Importance of low-grade albuminuria Mayo Clinic Proceedings 2008 83 7 806 812 (Pubitemid 351948694)
9. De Zeeuw D., Parving H. H., Henning R. H., Microalbuminuria as an early marker for cardiovascular disease Journal of the American Society of Nephrology 2006 17 8 2100 2105 (Pubitemid 44141898)
10. Hsu C. Y., McCulloch C. E., Iribarren C., Darbinian J., Go A. S., Body mass index and risk for end-stage renal disease Annals of Internal Medicine 2006 144 1 21 28 (Pubitemid 46780716)
11. Foley R. N., Parfrey P. S., Sarnak M. J., Clinical epidemiology of cardiovascular disease in chronic renal disease American Journal of Kidney Diseases 1998 32 5 S112 S119
12. Lindner A., Charra B., Sherrard D. J., Scribner B. H., Accelerated atherosclerosis in prolonged maintenance hemodialysis New England Journal of Medicine 1974 290 13 697 701
13. Vanholder R., Massy Z., Argiles A., Spasovski G., Verbeke F., Lameire N., Beige J., Brunet P., Cohen G., De Deyn P. P., Descamps-Latscha B., Herget-Rosenthal S., Hrl W., Jankowski J., Jrres A., Rodriguez M., Stegmayr B., Stenvinkel P., Wanner C., Weissinger E., Wiecek A., Zidek W., Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrology Dialysis Transplantation 2005 20 1048 1056 (Pubitemid 40862092)
14. Henry R. M. A., Kostense P. J., Bos G., Dekker J. M., Nijpels G., Heine R. J., Bouter L. M., Stehouwer C. D. A., Mild renal insufficiency is associated with increased cardiovascular mortality Kidney International 2002 62 4 1402 1407
15. Ninomiya T., Kiyohara Y., Kubo M., Metabolic syndrome and CKD in a general Japanese population: The Hisayama Study American Journal of Kidney Diseases 2006 48 3 383 391 (Pubitemid 44247252)
16. Chen J., Muntner P., Hamm L. L., Jones D. W., Batuman V., Fonseca V., Whelton P. K., He J., The metabolic syndrome and chronic kidney disease in U.S. adults Annals of Internal Medicine 2004 140 3 167 174
17. Perico N., Codreanu I., Schieppati A., Remuzzi G., Prevention of progression and remission/regression strategies for chronic renal diseases: can we do better now than five years ago? Kidney International 2005 68 98, supplement S21 S24
18. Bahrami H., Bluemke D. A., Kronmal R., Bertoni A. G., Lloyd-Jones D. M., Shahar E., Szklo M., Lima J. A. C., Novel metabolic risk factors for incident heart failure and their relationship with obesity. The MESA (Multi-Ethnic Study of Atherosclerosis) Study Journal of the American College of Cardiology 2008 51 18 1775 1783 (Pubitemid 351608497)
19. Wachtell K., Ibsen H., Olsen M. H., Borch-Johnsen K., Lindholm L. H., Mogensen C. E., Dahlf B., Devereux R. B., Beevers G., De Faire U., Fyhrquist F., Julius S., Kjeldsen S. E., Kristianson K., Lederballe-Pedersen O., Nieminen M. S., Okin P. M., Omvik P., Oparil S., Wedel H., Snapinn S. M., Aurup P., Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study Annals of Internal Medicine 2003 139 11 901 906
20. Wellen K. E., Hotamisligil G. S., Obesity-induced inflammatory changes in adipose tissue Journal of Clinical Investigation 2003 112 12 1785 1788 (Pubitemid 38063699)
21. Summers L. K. M., Samra J. S., Frayn K. N., Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk? Atherosclerosis 1999 147 1 11 15 (Pubitemid 29486767)
22. Ouchi N., Kihara S., Arita Y., Maeda K., Kuriyama H., Okamoto Y., Hotta K., Nishida M., Takahashi M., Nakamura T., Yamashita S., Funahashi T., Matsuzawa Y., Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation 1999 100 25 2473 2476 (Pubitemid 30005109)
23. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J. I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochemical and Biophysical Research Communications 1999 257 1 79 83 (Pubitemid 29299050)
24. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1595 1599 (Pubitemid 30353893)
25. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 (Pubitemid 38766330)
26. Nawrocki A. R., Scherer P. E., The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation Current Opinion in Pharmacology 2004 4 3 281 289 (Pubitemid 38585314)
27. Havel P. J., Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism Diabetes 2004 53 1 S143 S151
28. Shimada K., Miyazaki T., Daida H., Adiponectin and atherosclerotic disease Clinica Chimica Acta 2004 344 1-2 1 12 (Pubitemid 38626132)
29. Becker B., Kronenberg F., Kielstein J. T., Haller H., Morath C., Ritz E., Fliser D., Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study Journal of the American Society of Nephrology 2005 16 4 1091 1098 (Pubitemid 41710320)
30. Tsioufis C., Dimitriadis K., Chatzis D., Vasiliadou C., Tousoulis D., Papademetriou V., Toutouzas P., Stefanadis C., Kallikazaros I., Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension American Journal of Cardiology 2005 96 7 946 951 (Pubitemid 41362518)
31. Yano Y., Hoshide S., Ishikawa J., Hashimoto T., Eguchi K., Shimada K., Kario K., Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes Journal of Clinical Hypertension 2007 9 10 775 782
32. Sharma K., RamachandraRao S., Qiu G., Usui H. K., Zhu Y., Dunn S. R., Ouedraogo R., Hough K., McCue P., Chan L., Falkner B., Goldstein B. J., Adiponectin regulates albuminuria and podocyte function in mice Journal of Clinical Investigation 2008 118 5 1645 1656 (Pubitemid 351632369)
33. Koshimura J., Fujita H., Narita T., Shimotomai T., Hosoba M., Yoshioka N., Kakei M., Fujishima H., Ito S., Urinary adiponectin excretion is increased in patients with overt diabetic nephropathy Biochemical and Biophysical Research Communications 2004 316 1 165 169 (Pubitemid 38299140)
34. Jorsal A., Tarnow L., Frystyk J., Lajer M., Flyvbjerg A., Parving H. H., Vionnet N., Rossing P., Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy Kidney International 2008 74 5 649 654
35. Sharma K., The link between obesity and albuminuria: adiponectin and podocyte dysfunction Kidney International 2009 76 2 145 148
36. Eremina V., Baelde H. J., Quaggin S. E., Role of the VEGFa signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier Nephron Physiology 2007 106 2 p32 p37
37. Eremina V., Jefferson J. A., Kowalewska J., Hochster H., Haas M., Weisstuch J., Richardson C., Kopp J. B., Kabir M. G., Backx P. H., Gerber H. P., Ferrara N., Barisoni L., Alpers C. E., Quaggin S. E., VEGF inhibition and renal thrombotic microangiopathy New England Journal of Medicine 2008 358 11 1129 1136 (Pubitemid 351398487)
38. Friedman J. M., Halaas J. L., Leptin and the regulation of body weight in mammals Nature 1998 395 6704 763 770 (Pubitemid 28485436)
39. Ren J., Leptin and hyperleptinemiafrom friend to foe for cardiovascular function Journal of Endocrinology 2004 181 1 1 10 (Pubitemid 38584659)
40. Sderberg S., Ahrén B., Jansson J. H., Johnson O., Hallmans G., Asplund K., Olsson T., Leptin is associated with increased risk of myocardial infarction Journal of Internal Medicine 1999 246 4 409 418 (Pubitemid 29479923)
41. Corsonello A., Perticone F., Malara A., De Domenico D., Loddo S., Buemi M., Ientile R., Corica F., Leptin-dependent platelet aggregation in healthy, overweight and obese subjects International Journal of Obesity 2003 27 5 566 573 (Pubitemid 36561013)
42. Konstantinides S., Schfer K., Koschnick S., Loskutoff D. J., Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity Journal of Clinical Investigation 2001 108 10 1533 1540 (Pubitemid 33091991)
43. Konstantinides S., Schfer K., Loskutoff D. J., The prothrombotic effects of leptin: possible implications for the risk of cardiovascular disease in obesity Annals of the New York Academy of Sciences 2001 947 134 142 (Pubitemid 34059909)
44. Loffreda S., Yang S. Q., Lin H. Z., Karp C. L., Brengman M. L., Wang D. J., Klein A. S., Bulkley G. B., Bao C., Noble P. W., Lane M. D., Diehl A. M., Leptin regulates proinflammatory immune responses FASEB Journal 1998 12 1 57 65 (Pubitemid 28060271)
45. Parhami F., Tintut Y., Ballard A., Fogelman A. M., Demer L. L., Leptin enhances the calcification of vascular cells artery wall as a target of leptin Circulation Research 2001 88 9 954 960 (Pubitemid 32441475)
46. Laimer M., Ebenbichler C. F., Kaser S., Sandhofer A., Weiss H., Nehoda H., Aigner F., Patsch J. R., Markers of chronic inflammation and obesity: a prospective study on the reversibility of this association in middle-aged women undergoing weight loss by surgical intervention International Journal of Obesity 2002 26 5 659 662 (Pubitemid 34499286)
47. Maachi M., Piéroni L., Bruckert E., Jardel C., Fellahi S., Hainque B., Capeau J., Bastard J.-P., Systemic low-grade inflammation is related to both circulating and adipose tissue TNF, leptin and IL-6 levels in obese women International Journal of Obesity 2004 28 8 993 997 (Pubitemid 38998704)
48. Monzillo L. U., Hamdy O., Horton E. S., Ledbury S., Mullooly C., Jarema C., Porter S., Ovalle K., Moussa A., Mantzoros C. S., Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance Obesity Research 2003 11 9 1048 1054 (Pubitemid 41151581)
49. Papafragkaki D. K., Tolis G., Obesity and renal disease: a possible role of leptin Hormones 2005 4 2 90 95
50. Henegar J. R., Bigler S. A., Henegar L. K., Tyagi S. C., Hall J. E., Functional and structural changes in the kidney in the early stages of obesity Journal of the American Society of Nephrology 2001 12 6 1211 1217 (Pubitemid 32472634)
51. Kambham N., Markowitz G. S., Valeri A. M., Lin J., D'Agati V. D., Obesity-related glomerulopathy: an emerging epidemic Kidney International 2001 59 4 1498 1509 (Pubitemid 32281241)
52. Stenvinkel P., Leptin and its clinical implications in chronic renal failure Mineral and Electrolyte Metabolism 1999 25 4-6 298 302 (Pubitemid 30099680)
53. Adelman R. D., Obesity and renal disease Current Opinion in Nephrology and Hypertension 2002 11 3 331 335 (Pubitemid 34496782)
54. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K., Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 1999 402 6762 656 660 (Pubitemid 129516334)
55. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., Shimatsu A., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., Nakao K., Ghrelin strongly stimulates growth hormone (GH) release in humans Journal of Clinical Endocrinology and Metabolism 2000 85 12 4908 4911 (Pubitemid 32157685)
56. Iantorno M., Chen H., Kim J. A., Tesauro M., Lauro D., Cardillo C., Quon M. J., Ghrelin has novel vascular actions that mimic PI 3-kinase-dependent actions of insulin to stimulate production of NO from endothelial cells American Journal of Physiology 2007 292 3 E756 E764
57. Tesauro M., Iantorno M., Schinzari F., Cardillo C., Vascular effects of insulin and their relation to endothelial dysfunction, insulin resistance and hypertension Current Hypertension Reviews 2009 5 4 251 261
58. Tesauro M., Schinzari F., Iantorno M., Rizza S., Melina D., Lauro D., Cardillo C., Ghrelin improves endothelial function in patients with metabolic syndrome Circulation 2005 112 19 2986 2992 (Pubitemid 41612302)
59. Cano P., Cardinali D. P., Ros-Lugo M. J., Fernndez-Mateos M. P., Reyes Toso C. F., Esquifino A. I., Effect of a high-fat diet on 24-hour pattern of circulating adipocytokines in rats Obesity 2009 17 10 1866 1871
60. Berg A. H., Combs T. P., Du X., Brownlee M., Scherer P. E., The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nature Medicine 2001 7 8 947 953 (Pubitemid 32756433)
61. Fruebis J., Tsao T. S., Javorschi S., Ebbets-Reed D., Erickson M. R. S., Yen F. T., Bihain B. E., Lodish H. F., Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proceedings of the National Academy of Sciences of the United States of America 2001 98 4 2005 2010 (Pubitemid 32165613)
62. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- : direct role in obesity-linked insulin resistance Science 1993 259 5091 87 91 (Pubitemid 23036092)
63. Sowers J. R., Endocrine functions of adipose tissue: focus on adiponectin Clinical Cornerstone 2008 9 1 32 38
64. Goossens G. H., Blaak E. E., Van Baak M. A., Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders Obesity Reviews 2003 4 1 43 55 (Pubitemid 36356409)
65. Comstock K. L., Krown K. A., Page M. T., Martin D., Ho P., Pedraza M., Castro E. N., Nakajima N., Glembotski C. C., Quintana P. J. E., Sabbadini R. A., LPS-induced TNF- release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response Journal of Molecular and Cellular Cardiology 1998 30 12 2761 2775 (Pubitemid 29017515)
66. Mann D. L., Stress-activated cytokines and the heart: from adaptation to maladaptation Annual Review of Physiology 2003 65 81 101 (Pubitemid 38249148)
67. Torre-Amione G., Kapadia S., Lee J., Durand J. B., Bies R. D., Young J. B., Mann D. L., Tumor necrosis factor- and tumor necrosis factor receptors in the failing human heart Circulation 1996 93 4 704 711
68. Yokoyama T., Vaca L., Rossen R. D., Durante W., Hazarika P., Mann D. L., Cellular basis for the negative inotropic effects of tumor necrosis factor- in the adult mammalian heart Journal of Clinical Investigation 1993 92 5 2303 2312 (Pubitemid 23333536)
69. Sigusch H. H., Lehmann M. H., Schnittler U., Reinhardt D., Figulla H. R., Tumour necrosis factor- expression in idiopathic dilated cardiomyopathy: correlation to myocardial inflammatory activity Cytokine 2000 12 8 1261 1266 (Pubitemid 30611808)
70. Kapadia S., Lee J., Torre-Amione G., Birdsall H. H., Ma T. S., Mann D. L., Tumor necrosis factor- gene and protein expression in adult feline myocardium after endotoxin administration Journal of Clinical Investigation 1995 96 2 1042 1052
71. Kubota T., McTiernan C. F., Frye C. S., Demetris A. J., Feldman A. M., Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice Journal of Cardiac Failure 1997 3 2 117 124 (Pubitemid 127675015)
72. Bristow M. R., Tumor necrosis factor- and cardiomyopathy Circulation 1998 97 14 1340 1341
73. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D. R., Kumada M., Sato K., Schiekofer S., Ohashi K., Funahashi T., Colucci W. S., Walsh K., Adiponectin-mediated modulation of hypertrophic signals in the heart Nature Medicine 2004 10 12 1384 1389 (Pubitemid 40022722)
74. Dong F., Ren J., Adiponectin improves cardiomyocyte contractile fnction in db/db diabetic obese mice Obesity 2009 17 2 262 268
75. Ouchi N., Kihara S., Funahashi T., Matsuzawa Y., Walsh K., Obesity, adiponectin and vascular inflammatory disease Current Opinion in Lipidology 2003 14 6 561 566 (Pubitemid 41623184)
76. Chen H., Montagnani M., Funahashi T., Shimomura I., Quon M. J., Adiponectin stimulates production of nitric oxide in vascular endothelial cells Journal of Biological Chemistry 2003 278 45 45021 45026 (Pubitemid 37377262)
77. Cheng K. K. Y., Lam K. S. L., Wang Y., Huang Y., Carling D., Wu D., Wong C., Xu A., Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells Diabetes 2007 56 5 1387 1394 (Pubitemid 46715600)
78. Hong S. J., Park C. G., Seo H. S., Oh D. J., Ro Y. M., Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index Blood Pressure 2004 13 4 236 242 (Pubitemid 39248187)
79. Schulze P. C., Kratzsch J., Linke A., Schoene N., Adams V., Gielen S., Erbs S., Moebius-Winkler S., Schuler G., Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure European Journal of Heart Failure 2003 5 1 33 40 (Pubitemid 36205542)
80. Sderberg S., Ahrén B., Jansson J. H., Johnson O., Hallmans G., Asplund K., Olsson T., Leptin is associated with increased risk of myocardial infarction Journal of Internal Medicine 1999 246 4 409 418 (Pubitemid 29479923)
81. Wallace A. M., McMahon A. D., Packard C. J., Kelly A., Shepherd J., Gaw A., Sattar N., Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS) Circulation 2001 104 25 3052 3056 (Pubitemid 34014056)
82. Flanagan D. E., Vaile J. C., Petley G. W., Phillips D. I., Godsland I. F., Owens P., Moore V. M., Cockington R. A., Robinson J. S., Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system Regulatory Peptides 2007 140 1-2 37 42 (Pubitemid 46275057)
83. Menendez C., Baldelli R., Lage M., Casabiell X., Pinero V., Solar J., Dieguez C., Casanueva F. F., The in vitro secretion of human leptin is gender-dependent but independent of the body mass index of the donors European Journal of Endocrinology 2000 143 5 711 714
84. Bodary P. F., Westrick R. J., Wickenheiser K. J., Shen Y., Eitzman D. T., Effect of leptin on arterial thrombosis following vascular injury in mice Journal of the American Medical Association 2002 287 13 1706 1709 (Pubitemid 34289223)
85. Cooke J. P., Oka R. K., Does leptin cause vascular disease? Circulation 2002 106 15 1904 1905 (Pubitemid 35176291)
86. Chaldakov G. N., Fiore M., Stankulov I. S., Hristova M., Antonelli A., Manni L., Ghenev P. I., Angelucci F., Aloe L., NGF, BDNF, leptin, and mast cells in human coronary atherosclerosis and metabolic syndrome Archives of Physiology and Biochemistry 2001 109 4 357 360 (Pubitemid 35216883)
87. Chu N.-F., Spiegelman D., Rifai N., Hotamisligil G. S., Rimm E. B., Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men International Journal of Obesity 2000 24 9 1085 1092
88. Sierra-Honigmann M. R., Nath A. K., Murakami C., Garca-Cardea G., Papapetropoulos A., Sessa W. C., Madge L. A., Schechner J. S., Schwabb M. B., Polverini P. J., Flores-Riveros J. R., Biological action of leptin as an angiogenic factor Science 1998 281 5383 1683 1686 (Pubitemid 28435586)
89. Singhal A., Farooqi S., Cole T. J., O'Rahilly S., Fewtrell M., Kattenhorn M., Lucas A., Deanfield J., Influence of leptin on arterial distensibility: a novel link between obesity and cardiovascular disease? Circulation 2002 106 15 1919 1924 (Pubitemid 35176295)
90. Nagaya N., Uematsu M., Kojima M., Date Y., Nakazato M., Okumura H., Hosoda H., Shimizu W., Yamagishi M., Oya H., Koh H., Yutani C., Kangawa K., Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors Circulation 2001 104 17 2034 2038 (Pubitemid 33027043)
91. Frascarelli S., Ghelardoni S., Ronca-Testoni S., Zucchi R., Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart Basic Research in Cardiology 2003 98 6 401 405 (Pubitemid 37336627)
92. Nagaya N., Uematsu M., Kojima M., Ikeda Y., Yoshihara F., Shimizu W., Hosoda H., Hirota Y., Ishida H., Mori H., Kangawa K., Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure Circulation 2001 104 12 1430 1435 (Pubitemid 32880158)
93. Nagaya N., Kojima M., Uematsu M., Yamagishi M., Hosoda H., Oya H., Hayashi Y., Kangawa K., Hemodynamic and hormonal effects of human ghrelin in healthy volunteers American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2001 280 5 R1483 R1487
94. Nagaya N., Kangawa K., Therapeutic potential of Ghrelin in the treatment of heart failure Drugs 2006 66 4 439 448
95. Nagaya N., Miyatake K., Uematsu M., Oya H., Shimizu W., Hosoda H., Kojima M., Nakanishi N., Mori H., Kangawa K., Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure Journal of Clinical Endocrinology and Metabolism 2001 86 12 5854 5859 (Pubitemid 33152634)
96. Nagaya N., Moriya J., Yasumura Y., Uematsu M., Ono F., Shimizu W., Ueno K., Kitakaze M., Miyatake K., Kangawa K., Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure Circulation 2004 110 24 3674 3679 (Pubitemid 39665256)
97. Kamei N., Tobe K., Suzuki R., Ohsugi M., Watanabe T., Kubota N., Ohtsuka-Kowatari N., Kumagai K., Sakamoto K., Kobayashi M., Yamauchi T., Ueki K., Oishi Y., Nishimura S., Manabe I., Hashimoto H., Ohnishi Y., Ogata H., Tokuyama K., Tsunoda M., Ide T., Murakami K., Nagai R., Kadowaki T., Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance Journal of Biological Chemistry 2006 281 36 26602 26614 (Pubitemid 44401869)
98. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance Journal of Clinical Investigation 2003 112 12 1821 1830 (Pubitemid 38063705)
99. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W., Obesity is associated with macrophage accumulation in adipose tissue Journal of Clinical Investigation 2003 112 12 1796 1808 (Pubitemid 38063703)
100. Sowers J. R., Metabolic risk factors and renal disease Kidney International 2007 71 8 719 720 (Pubitemid 46624014)
101. Weisberg S. P., McCann D., Desai M., Rosenbaum M., Leibel R. L., Ferrante A. W. Jr., Obesity is associated with macrophage accumulation in adipose tissue Journal of Clinical Investigation 2003 112 12 1796 1808 (Pubitemid 38063703)
102. Curat C. A., Miranville A., Sengens C., Diehl M., Tonus C., Busse R., Bouloumié A., From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes Diabetes 2004 53 5 1285 1292 (Pubitemid 38569015)
103. Cancello R., Tordjman J., Poitou C., Guilhem G., Bouillot J. L., Hugol D., Coussieu C., Basdevant A., Hen A. B., Bedossa P., Guerre-Millo M., Clément K., Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 2006 55 6 1554 1561 (Pubitemid 44324107)
104. Zeng G., Nystrom F. H., Ravichandran L. V., Cong LI. N., Kirby M., Mostowski H., Quon M. J., Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells Circulation 2000 101 13 1539 1545 (Pubitemid 30180890)
105. Begum N., Ragolia L., Effect of tumor necrosis factor- on insulin action in cultured rat skeletal muscle cells Endocrinology 1996 137 6 2441 2446 (Pubitemid 26155780)
106. Suganami T., Nishida J., Ogawa Y., A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 10 2062 2068 (Pubitemid 41416301)
107. Hotamisligil G. S., Inflammation and metabolic disorders Nature 2006 444 7121 860 867 (Pubitemid 46024993)
108. Tesauro M., Schinzari F., Rovella V., Melina D., Mores N., Barini A., Mettimano M., Lauro D., Iantorno M., Quon M. J., Cardillo C., TNF-alpha antagonism improves insulin-stimulated vasodilation in metabolic syndrome Diabetes Care 2008 31 7 1439 1441
109. Gimeno R. E., Klaman L. D., Adipose tissue as an active endocrine organ: recent advances Current Opinion in Pharmacology 2005 5 2 122 128 (Pubitemid 40378741)
110. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A. B., Benoist C., Shoelson S., Mathis D., Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters Nature Medicine 2009 15 8 930 939
111. Iacobellis G., di Gioia C. R., Cotesta D., Petramala L., Travaglini C., De Santis V., Vitale D., Tritapepe L., Letizia C., Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels Hormone and Metabolic Research 2009 41 3 227 231
112. Barbaro G., Iacobellis G., Metabolic syndrome associated with HIV and highly active antiretroviral therapy Current Diabetes Reports 2009 9 1 37 42
113. Iacobellis G., Pistilli D., Gucciardo M., Leonetti F., Miraldi F., Brancaccio G., Gallo P., Tiziana Di Gioia C. R., Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease Cytokine 2005 29 6 251 255 (Pubitemid 40320925)
114. Mazurek T., Zhang L., Zalewski A., Mannion J. D., Diehl J. T., Arafat H., Sarov-Blat L., O'Brien S., Keiper E. A., Johnson A. G., Martin J., Goldstein B. J., Shi YI., Human epicardial adipose tissue is a source of inflammatory mediators Circulation 2003 108 20 2460 2466 (Pubitemid 37444406)
115. Baker A. R., da Silva N. F., Quinn D. W., Harte A. L., Pagano D., Bonser R. S., Kumar S., McTernan P. G., Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease Cardiovascular Diabetology 2006 5, article 1
116. Chaldakov G. N., Fiore M., Stankulov I. S., Manni L., Hristova M. G., Antonelli A., Ghenev P. I., Aloe L., Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Progress in Brain Research 2004 146 279 289 (Pubitemid 37541389)
117. Kremen J., Dolinkova M., Krajickova J., Blaha J., Anderlova K., Lacinova Z., Haluzikova D., Bosanska L., Vokurka M., Svacina S., Haluzik M., Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance Journal of Clinical Endocrinology and Metabolism 2006 91 11 4620 4627 (Pubitemid 44833447)
118. Gao Y. J., Zeng Z. H., Teoh K., Sharma A. M., Abouzahr L., Cybulsky I., Lamy A., Semelhago L., Lee R. M. K. W., Perivascular adipose tissue modulates vascular function in the human internal thoracic artery Journal of Thoracic and Cardiovascular Surgery 2005 130 4 1130 1136 (Pubitemid 41427351)
119. Greenstein A. S., Khavandi K., Withers S. B., Sonoyama K., Clancy O., Jeziorska M., Laing I., Yates A. P., Pemberton P. W., Malik R. A., Heagerty A. M., Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients Circulation 2009 119 12 1661 1670
120. Djaberi R., Schuijf J. D., van Werkhoven J. M., Nucifora G., Jukema J. W., Bax J. J., Relation of epicardial adipose tissue to coronary atherosclerosis American Journal of Cardiology 2008 102 12 1602 1607
121. Hosogai N., Fukuhara A., Oshima K., Miyata Y., Tanaka S., Segawa K., Furukawa S., Tochino Y., Komuro R., Matsuda M., Shimomura I., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation Diabetes 2007 56 4 901 911 (Pubitemid 46525054)
122. Kambham N., Markowitz G. S., Valeri A. M., Lin J., D'Agati V. D., Obesity-related glomerulopathy: an emerging epidemic Kidney International 2001 59 4 1498 1509 (Pubitemid 32281241)
123. Lamacchia O., Nicastro V., Camarchio D., Para and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients. Nephrology, Dialysis, Transplantation. In press
124. Papafragkaki D. K., Tolis G., Obesity and renal disease: a possible role of leptin Hormones 2005 4 2 90 95
125. Hall J. E., Jones D. W., Kuo J. J., da Silva A., Tallam L. S., Liu J., Impact of the obesity epidemic on hypertension and renal disease Current Hypertension Reports 2003 5 5 386 392 (Pubitemid 38898962)
126. Morales E., Valero M. A., Len M., Hernndez E., Praga M., Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies American Journal of Kidney Diseases 2003 41 2 319 327 (Pubitemid 36152449)
127. Praga M., Hernandez E., Herrero J. C., Morales E., Revilla Y., Diaz-Gonzalez R., Rodicio J. L., Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy Kidney International 2000 58 5 2111 2118
128. Rask-Madsen C., Domnguez H., Ihlemann N., Hermann T., Kber L., Torp-Pedersen C., Tumor necrosis factor-α inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans Circulation 2003 108 15 1815 1821 (Pubitemid 37296090)
129. Picchi A., Gao X., Belmadani S., Potter B. J., Focardi M., Chilian W. M., Zhang C., Tumor necrosis factor- induces endothelial dysfunction in the prediabetic metabolic syndrome Circulation Research 2006 99 1 69 77 (Pubitemid 44297057)
130. Caballero A. E., Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease Obesity Research 2003 11 11 1278 1289 (Pubitemid 41127348)
131. De Kreutzenberg S. V., Puato M., Kiwanuka E., Del Prato S., Pauletto P., Pasini L., Tiengo A., Avogaro A., Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels Atherosclerosis 2003 169 1 147 153 (Pubitemid 36830933)
132. Griffin M. E., Marcucci M. J., Cline G. W., Bell K., Barucci N., Lee D.,
133. Shi H., Kokoeva M. V., Inouye K., Tzameli I., Yin H., Flier J. S., TLR4 links innate immunity and fatty acid-induced insulin resistance Journal of Clinical Investigation 2006 116 11 3015 3025 (Pubitemid 44684486)
134. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 2006 440 7086 944 948
135. Zeng G., Quon M. J., Insulin-stimulated production of nitric oxide is inhibited by Wortmannin: direct measurement in vascular endothelial cells Journal of Clinical Investigation 1996 98 4 894 898 (Pubitemid 26293305)
136. Vincent M. A., Clerk L. H., Lindner J. R., Klibanov A. L., Clark M. G., Rattigan S., Barrett E. J., Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo Diabetes 2004 53 6 1418 1423 (Pubitemid 38697651)
137. Nystrom F. H., Quon M., Insulin signalling: metabolic pathways and mechanisms for specificity Cellular Signalling 1999 11 8 563 574 (Pubitemid 29255888)
138. Adams V., Linke A., Krnkel N., Erbs S., Gielen S., Mbius-Winkler S., Gummert J. F., Mohr F. W., Schuler G., Hambrecht R., Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease Circulation 2005 111 5 555 562 (Pubitemid 40216482)
139. Kelly L. K., Wedgwood S., Steinhorn R. H., Black S. M., Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclise American Journal of Physiology 2004 286 5 L984 L991
140. Muniyappa R., Iantorno M., Quon M. J., An integrated view of insulin resistance and endothelial dysfunction Endocrinology and Metabolism Clinics of North America 2008 37 3 685 711
141. Lteif A., Vaishnava P., Baron A. D., Mather K. J., Endothelin limits insulin action in obese/insulin-resistant humans Diabetes 2007 56 3 728 734 (Pubitemid 46348477)
142. Ahlborg G., Shemyakin A., Bhm F., Gonon A., Pernow J., Dual endothelin receptor blockade acutely improves insulin sensitivity in obese patients with insulin resistance and coronary artery disease Diabetes Care 2007 30 3 591 596 (Pubitemid 46354339)
143. Vincent M. A., Montagnani M., Quon M. J., Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium Current Diabetes Reports 2003 3 4 279 288 (Pubitemid 38906783)
144. Montagnani M., Chen H., Barr V. A., Quon M. J., Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser Journal of Biological Chemistry 2001 276 32 30392 30398
145. Schinzari F., Tesauro M., Rovella V., Galli A., Mores N., Porzio O., Lauro D., Cardillo C., Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome American Journal of Physiology 2010 299 6 E947 E952
146. Stevens V. J., Obarzanek E., Cook N. R., Lee I. M., Appel L. J., West D. S., Milas N. C., Mattfeldt-Beman M., Belden L., Bragg C., Millstone M., Raczynski J., Brewer A., Singh B., Cohen J., Long-term weight loss and changes in blood pressure: results of the trials of hypertension prevention, phase II Annals of Internal Medicine 2001 134 1 1 11 (Pubitemid 32037337)